GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.

Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of ...

GE HealthCare will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese ...

GE HealthCare has owned half of Nihon Medi-Physics since 2004, when former parent company General Electric obtained the stake ...

GE HealthCare (GEHC) has agreed to acquire full ownership of Nihon Medi-Physics, by purchasing from Sumitomo Chemical the 50% stake it does not ...

GE HealthCare (Nasdaq: GEHC) has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing f ...

GE HealthCare to buy remaining 50% stake in Japanese radiopharmaceutical company, Nihon Medi-Physics from Sumitomo Chemical: Chalfont St Giles, UK Monday, December 2, 2024, 14:00 ...

Sumitomo Chemical Co (JP:4005) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium ...

GE HealthCare (GEHC) has agreed to acquire the remaining 50% stake in Nihon Medi-Physics ((NMP)) from Sumitomo Chemical. Read ...

Renalys Pharma, Inc., a late-stage clinical biopharmaceutical company announces that sparsentan, in-licensed from Travere Therapeutics, Inc. ("Travere") and currently in phase III clinical trials in ...

Morphing I, a global leader in AI-based infrastructure solutions founded in 2021, is redefining industry standards by ...

GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP, subject to regulatory approvals As ...